1,10-phenanthroline has been researched along with promegestone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burkley, M; Dinda, S; Hurd, C; Kodali-Gali, S; Moudgil, VK; Sevilla, L | 1 |
1 other study(ies) available for 1,10-phenanthroline and promegestone
Article | Year |
---|---|
Inhibition of proliferation of T47D human breast cancer cells: alterations in progesterone receptor and p53 tumor suppressor protein.
Topics: Antineoplastic Agents; Aurintricarboxylic Acid; Blotting, Western; Breast Neoplasms; Cell Division; DNA-Binding Proteins; Down-Regulation; Drug Screening Assays, Antitumor; Electrophoresis, Polyacrylamide Gel; Humans; Neoplasms, Hormone-Dependent; Phenanthrolines; Progesterone Congeners; Promegestone; Receptors, Progesterone; Rifampin; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1997 |